Harold Rogers Prescription Drug Monitoring Program

Program goal(s) name: Strengthen states and territories’ ability to maintain and enhance PDMPs and data integration to inform clinical decision making and abuse of prescription drugs.
Program goal(s) description: Support state and local governments to encourage the use of PDMPs, integration of PDMP data with health information exchanges (HIE), electronic health records (EHR), or pharmacy dispensing systems (PDS), and engaging with tribal entities and rural areas where integration rates may be lower to improve clinical decision making and detecting and preventing the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. This program helps to break the cycle of drug addiction and violence by reducing the demand for, use, and the illegal trafficking of controlled substances.
Program objective(s) name: Strengthen capacity and facilitate use of prescription drug data
Program objective(s) description: Strengthen capacity of PDMPs to share information on prescribing, dispensing, and use of prescription drugs within and between states using preferred method of choice, and via RxCheck Hub; Facilitate use of PDMP data to support law enforcement efforts, allocation of substance use disorder treatment and prevention resources, and sound clinical decision making among prescribers; and Design, implement, and advance initiatives to improve linkage, analysis, reporting, usage, and sharing of PDMP derived data.

All final award decisions will be made by the Assistant Attorney General, unless a statute explicitly authorizes award decisions by another official or there is written delegation of authority to another official. For successful applicants, JustGrants will send a system-generated email to the Application Submitter, Authorized Representative, and Entity Administrator with information on accessing their official award package in JustGrants. The award package will include key information (such as funding amount and period of performance) as well as award conditions that must be followed. The Authorized Representative for the entity should accept or decline the award within 45 days of the notification.

The review procedure for applications is specified in the notice of funding opportunity (NOFO) and generally includes eligibility and responsiveness, merit, programmatic, budget, and risk reviews.